Laura Hasselbach

917 total citations
13 papers, 691 citations indexed

About

Laura Hasselbach is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Laura Hasselbach has authored 13 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Laura Hasselbach's work include Glioma Diagnosis and Treatment (6 papers), Cancer Cells and Metastasis (4 papers) and MicroRNA in disease regulation (3 papers). Laura Hasselbach is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Cancer Cells and Metastasis (4 papers) and MicroRNA in disease regulation (3 papers). Laura Hasselbach collaborates with scholars based in United States, Germany and Israel. Laura Hasselbach's co-authors include H W Stürzbecher, Tom Mikkelsen, Kirsten Jost, Sven Opitz, Jütta Lüttges, Holger Kalthoff, Heiko Maacke, Yate‐Ching Yuan, Stefan Miska and Ana C. deCarvalho and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Laura Hasselbach

11 papers receiving 684 citations

Peers

Laura Hasselbach

MB

CR

ONCOL

GENET

PRM

Gregory Foltz United States

Tatsuya Takezaki Japan

Danny A. Zwijnenburg Netherlands

Rut Tejero Spain

Y. Piao United States

Christopher J. Pirozzi United States

Thale Kristin Olsen Sweden

Kathy Astrahantseff Germany

Hye-Min Jeon South Korea

I‐Mei Siu United States

Gregory Foltz United States

Laura Hasselbach

546 ×1.1

MB

337 ×1.2

CR

261 ×1.2

ONCOL

142 ×0.8

GENET

61 ×1.2

PRM

Citations per year, relative to Laura Hasselbach Laura Hasselbach (= 1×) peers Gregory Foltz

Countries citing papers authored by Laura Hasselbach

Since Specialization

Citations

This map shows the geographic impact of Laura Hasselbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Hasselbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Hasselbach more than expected).

Fields of papers citing papers by Laura Hasselbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Hasselbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Hasselbach. The network helps show where Laura Hasselbach may publish in the future.

Co-authorship network of co-authors of Laura Hasselbach

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Hasselbach. A scholar is included among the top collaborators of Laura Hasselbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Hasselbach. Laura Hasselbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Datta, Indrani, Kimberly Bergman, Thaís S. Sabedot, et al.. (2025). Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment. PLoS ONE. 20(2). e0315171–e0315171.

2.

Nagaraja, Tavarekere N., Ana C. deCarvalho, Stephen L. Brown, et al.. (2021). The impact of initial tumor microenvironment on imaging phenotype. Cancer Treatment and Research Communications. 27. 100315–100315. 2 indexed citations

3.

deCarvalho, Ana C., et al.. (2018). Abstract 2519: Identification of novel MET fusion transcript amplification in glioblastoma. Cancer Research. 78(13_Supplement). 2519–2519.

4.

Irtenkauf, Susan M., et al.. (2017). Optimization of Glioblastoma Mouse Orthotopic Xenograft Models for Translational Research.. PubMed. 67(4). 300–314. 25 indexed citations

5.

Bergman, Kimberly, Susan M. Irtenkauf, Laura Hasselbach, et al.. (2015). Abstract 1755: TORK/DNA-PK inhibitor CC-115 is effective as a single agent in a subset of glioblastoma patient-derived cancer stem cells and xenografts and potentiates temozolomide therapy. Cancer Research. 75(15_Supplement). 1755–1755. 2 indexed citations

6.

Poisson, Laila, David Cherba, Craig P. Webb, et al.. (2014). Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation. Neoplasia. 16(3). 193–206.e25. 123 indexed citations

7.

Hasselbach, Laura, Susan M. Irtenkauf, Nancy Lemke, et al.. (2014). Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry. Journal of Visualized Experiments. 7 indexed citations

8.

Hasselbach, Laura, Susan M. Irtenkauf, Nancy Lemke, et al.. (2014). Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry. Journal of Visualized Experiments. e51088–e51088. 32 indexed citations

9.

Mikkelsen, T., Kimberly E. Arnold, Claudius Mueller, et al.. (2014). CABOZANTINIB IS EFFECTIVE IN A SUBSET OF XENOGRAFT GBM TUMORS AND AFFECTS MULTIPLE SIGNALING PATHWAYS. Neuro-Oncology. 16(suppl 3). iii38–iii38. 1 indexed citations

10.

Lee, Hae Kyung, Susan Finniss, Simona Cazacu, et al.. (2013). Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Oncotarget. 4(2). 346–361. 192 indexed citations

11.

Mikkelsen, Tom, Thomas J. Doyle, John E. Anderson, et al.. (2008). Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma. Journal of Neuro-Oncology. 92(1). 57–63. 30 indexed citations

12.

Hasselbach, Laura, Steven B. Haase, Dagmar Fischer, Hans‐Christian Kolberg, & H W Stürzbecher. (2005). Characterisation of the promoter region of the human DNA-repair gene Rad51.. PubMed. 26(6). 589–98. 97 indexed citations

13.

Maacke, Heiko, Kirsten Jost, Sven Opitz, et al.. (2000). DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene. 19(23). 2791–2795. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact